Rosiglitazone : risque cardiovasculaire confirméChevalier, Pierre(2008) Minerva — Vol. 7, n° 4, p. 64 (2008)
Files240111.pdf Restricted Access Adobe PDF536.62 KBRequest a copyDetailsAuthorsChevalier, PierreUCLouvainAuthorAffiliationsUCLouvainMD/ESP - Ecole de santé publiqueShow moreCitations APA Chicago FWB Chevalier, P. (2008). Rosiglitazone : risque cardiovasculaire confirmé. Minerva, 7(4), 64. https://hdl.handle.net/2078.5/122369 (Original work published 2008)